-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acloproxalap in Alcohol Poisoning
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acloproxalap in Alcohol Poisoning Drug Details: Acloproxalap (ADX-629) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CB-010 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-010 in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CB-010 in Follicular Lymphoma Drug Details: CB-010 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BT-1053 in Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BT-1053 in Lymphoma Drug Details:BT-1053 is under development for the treatment of lymphoma. The drug candidate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bersacapavir in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bersacapavir in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bersacapavir in Hepatitis B Drug Details: JNJ-6379 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Petosemtamab in Anal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Petosemtamab in Anal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Petosemtamab in Anal Cancer Drug Details:Petosemtamab (MCLA-158) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Petosemtamab in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Petosemtamab in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Petosemtamab in Non-Small Cell Lung Cancer Drug Details:Petosemtamab (MCLA-158) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OX-40 Agonist Mab in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OX-40 Agonist Mab in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OX-40 Agonist Mab in Solid Tumor Drug Details: Monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-1569912 in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-1569912 in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BI-1569912 in Major Depressive Disorder Drug Details:BI-1569912 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AVI-4015 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVI-4015 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AVI-4015 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: AVI-4015 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SNK-01 in Chondrosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SNK-01 in Chondrosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SNK-01 in ChondrosarcomaDrug Details:SNK-01 is under development for the treatment of Alzheimer's disease, mild...